Literature DB >> 23344888

High risk of primary liver cancer in a cohort of 179 patients with Acute Hepatic Porphyria.

Eliane Sardh1, Staffan Wahlin, Mikael Björnstedt, Pauline Harper, Dan E H Andersson.   

Abstract

BACKGROUND/AIMS: Previous studies have indicated a high risk of hepatocellular carcinoma in acute hepatic porphyrias. In this retrospective study we present the incidence of primary liver cancer and clinical characteristics in a cohort of 179 acute porphyria patients above the age of 50 years.
METHODS: Twenty-three cases with primary liver cancer were found either by a surveillance program or due to clinical suspicion. Standardized rate ratio was used to estimate the relative risk of primary liver cancer after indirect standardization. Survival data were calculated using the Kaplan-Meier method.
RESULTS: The mean age at diagnosis was 69 years. Hepatocellular carcinoma was found in 19 patients while four patients had cholangiocarcinoma or a combination of the two. Four patients had underlying cirrhosis. Mean tumour size was 4.3 cm in the surveillance group and 10.3 cm in the non-surveillance group (p = 0.01). The overall relative risk of primary liver cancer was 86 above the age of 50: 150 for women and 37 for men. Mean survival time was 5.7 years.
CONCLUSION: Acute hepatic porphyria carries a high risk of primary liver cancer above the age of 50 which warrants ultrasound surveillance. Sex distribution and frequency of cirrhosis differs from more common aetiologies of primary liver cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23344888     DOI: 10.1007/s10545-012-9576-9

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  27 in total

1.  Treatment options in acute porphyria, porphyria cutanea tarda, and erythropoietic protoporphyria.

Authors:  Pauline Harper; Staffan Wahlin
Journal:  Curr Treat Options Gastroenterol       Date:  2007-12

2.  [Late first appearance of porphyria in a patient with primary liver cancer].

Authors:  G Lindstedt; L W Nillroth; C von Schéele; U Schelin; B Swolin; L Zettergren
Journal:  Lakartidningen       Date:  1973-11-21

3.  Hepatocellular carcinoma in patients from northern Sweden with acute intermittent porphyria: morphology and mutations.

Authors:  L Bjersing; C Andersson; F Lithner
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1996-05       Impact factor: 4.254

Review 4.  Primary liver cancer: worldwide incidence and trends.

Authors:  F Xavier Bosch; Josepa Ribes; Mireia Díaz; Ramon Cléries
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

Review 5.  Liver transplantation for porphyria: who, when, and how?

Authors:  Avnish Kumar Seth; Michael N Badminton; Darius Mirza; Scott Russell; Elwyn Elias
Journal:  Liver Transpl       Date:  2007-09       Impact factor: 5.799

6.  Prognosis of acute porphyria: occurrence of acute attacks, precipitating factors, and associated diseases.

Authors:  R Kauppinen; P Mustajoki
Journal:  Medicine (Baltimore)       Date:  1992-01       Impact factor: 1.889

7.  Abnormalities in liver function and morphology and impaired aminopyrine metabolism in hereditary hepatic porphyrias.

Authors:  J Ostrowski; E Kostrzewska; T Michalak; B Zawirska; W Medrzejewski; A Gregor
Journal:  Gastroenterology       Date:  1983-11       Impact factor: 22.682

Review 8.  Porphyria in Sweden.

Authors:  S Thunell; Y Floderus; A Henrichson; P Harper
Journal:  Physiol Res       Date:  2006       Impact factor: 1.881

9.  Porphyrias, porphyrins and hepatocellular cancer.

Authors:  N O Bengtsson; L Hardell
Journal:  Br J Cancer       Date:  1986-07       Impact factor: 7.640

10.  Aetiological aspects on primary liver cancer with special regard to alcohol, organic solvents and acute intermittent porphyria--an epidemiological investigation.

Authors:  L Hardell; N O Bengtsson; U Jonsson; S Eriksson; L G Larsson
Journal:  Br J Cancer       Date:  1984-09       Impact factor: 7.640

View more
  19 in total

1.  Effect of 5-aminolevulinic acid on the expression of carcinogenesis-related proteins in cultured primary hepatocytes.

Authors:  P R Menezes; C B González; A O DeSouza; D A Maria; J Onuki
Journal:  Mol Biol Rep       Date:  2018-09-14       Impact factor: 2.316

Review 2.  Hepatic porphyria: A narrative review.

Authors:  Sumant Arora; Steven Young; Sudha Kodali; Ashwani K Singal
Journal:  Indian J Gastroenterol       Date:  2016-10-31

3.  Occurrence of Malignant Tumours in the Acute Hepatic Porphyrias.

Authors:  Estefanía Lang; Martin Schäfer; Holger Schwender; Norbert J Neumann; Jorge Frank
Journal:  JIMD Rep       Date:  2015-02-22

Review 4.  Acute hepatic porphyrias: Recommendations for evaluation and long-term management.

Authors:  Manisha Balwani; Bruce Wang; Karl E Anderson; Joseph R Bloomer; D Montgomery Bissell; Herbert L Bonkovsky; John D Phillips; Robert J Desnick
Journal:  Hepatology       Date:  2017-09-04       Impact factor: 17.425

Review 5.  The acute hepatic porphyrias.

Authors:  Bruce Wang
Journal:  Transl Gastroenterol Hepatol       Date:  2021-04-05

6.  Audit of the Use of Regular Haem Arginate Infusions in Patients with Acute Porphyria to Prevent Recurrent Symptoms.

Authors:  Joanne T Marsden; Simon Guppy; Penelope Stein; Timothy M Cox; Michael Badminton; Tricia Gardiner; Julian H Barth; M Felicity Stewart; David C Rees
Journal:  JIMD Rep       Date:  2015-03-12

7.  Cimetidine/lactulose therapy ameliorates erythropoietic protoporphyria-related liver injury.

Authors:  Naoyuki Fujimori; Michiharu Komatsu; Naoki Tanaka; Mai Iwaya; Hajime Nakano; Ayumi Sugiura; Tomoo Yamazaki; Soichiro Shibata; Yugo Iwaya; Takashi Muraki; Yuki Ichikawa; Takefumi Kimura; Satoru Joshita; Takeji Umemura; Akihiro Matsumoto; Eiji Tanaka
Journal:  Clin J Gastroenterol       Date:  2017-07-04

Review 8.  Acute Hepatic Porphyria.

Authors:  D Montgomery Bissell; Bruce Wang
Journal:  J Clin Transl Hepatol       Date:  2015-03-15

9.  Medical and financial burden of acute intermittent porphyria.

Authors:  Rochus A Neeleman; Margreet A E M Wagenmakers; Rita H Koole-Lesuis; G Sophie Mijnhout; J H Paul Wilson; Edith C H Friesema; Janneke G Langendonk
Journal:  J Inherit Metab Dis       Date:  2018-04-19       Impact factor: 4.982

Review 10.  An update of clinical management of acute intermittent porphyria.

Authors:  Elena Pischik; Raili Kauppinen
Journal:  Appl Clin Genet       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.